Program

For information, please contact Nicole Levesque (levesque@hsph.harvard.edu, 617-432-4902)

Monday, May 17, 2021
Virtual Meeting via Zoom and all times below are EDT

8:30 – 8:45	Welcome & Introduction
8:45 – 9:00	Yasmine Belkaid, NIH/NIAID Opening Remarks
9:00 – 10:00	Maria Gloria Dominguez-Bello, Rutgers University “The human microbiome in a disruptive era”
10:00 – 10:30	Amy Willis, University of Washington “Estimating microbial abundances from high-throughput sequencing”
10:30 – 10:45	Caroline Young, University of Leeds “Screening potential of the CRC-associated microbiome”
10:45 – 11:00	Marissa Bivins, University of North Carolina, Chapel Hill “Discovery of the Gut Microbial Enzymes that Drive the Dose-Limiting Toxicity of the Immunosuppressant Mycophenolate Mofetil”
11:00 – 11:15	Break
11:15 – 11:45	Liz Johnson, Cornell University “Dietary lipids as modulators of microbiome function”
11:45 – 12:15	Greg Caporaso, Northern Arizona University “Accessible and reproducible microbiome multi-omics bioinformatics with QIIME 2”
12:15 – 1:30	Lunch Break
1:30 – 2:00	Dong Daniel Wang, Harvard Medical School, Brigham & Women’s Hospital “The Gut Microbiome Modifies the Associations between Diet and Cardiometabolic Disease Risk”
2:00 – 2:15	Apollo Stacy, NIH/NIGMS “Infection trains the host for microbiota-enhanced resistance to pathogens”
2:15 – 2:30	Amrisha Bhosle, Broad Institute & Harvard T.H. Chan School of Public Health “Prioritization and Annotation of Novel Bioactive Small Molecules from the Microbiome”
2:30 – 2:45	Break
2:45 – 3:15	Elaine Hsiao, University of California, Los Angeles “Interactions between the microbiome and nervous system during early neurodevelopment”
3:15 – 4:15	Peter Turnbaugh, University of California, San Francisco “The tiny pharmacists within: how the microbiome impacts the treatment of chronic and infectious diseases”
4:15 – 4:30	Closing Remarks
	Poster Reception available online all day here